XFOR

X4 Pharmaceuticals Inc

Jun 18 • 12:07PM ET

4.12

+0.07 1.69 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BMRN INCY KRYS KYMR NUVL RYTM VKTX AXSM MDGL NBIX

| Held by: VTI VXF AVSC PRFZ BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.54	Insider Own	19.50%	Shs Outstand	94.32M	Perf Week	6.14%
Market Cap	388.43M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.09%	Shs Float	75.92M	Perf Month	13.14%
Enterprise Value	231.96M	PEG	-	EPS next Q	-0.18	Inst Own	82.79%	Short Float	4.44%	Perf Quarter	-1.24%
Income	-99.72M	P/S	43.11	EPS this Y	60.96%	Inst Trans	2.87%	Short Ratio	8.47	Perf Half Y	11.01%
Sales	9.01M	P/B	2.31	EPS next Y	-9.25%	ROA	-49.82%	Short Interest	3.37M	Perf YTD	2.96%
Book/sh	1.79	P/C	1.66	EPS next 5Y	27.70%	ROE	-104.21%	52W High	4.83 -14.73%	Perf Year	46.04%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	65.48% 54.19%	ROIC	-40.71%	52W Low	1.35 205.06%	Perf 3Y	-93.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 63.56%	Gross Margin	79.04%	Volatility	3.82% 5.49%	Perf 5Y	-98.15%
Dividend TTM	-	EV/Sales	25.74	EPS Y/Y TTM	-300.04%	Oper. Margin	-1084.38%	ATR (14)	0.21	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.98	Sales Y/Y TTM	-71.26%	Profit Margin	-1106.30%	RSI (14)	54.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.18	EPS Q/Q	-490.02%	SMA20	2.99%	Beta	0.38	Target Price	11.75
Payout	-	Debt/Eq	0.46	Sales Q/Q	-90.60%	SMA50	0.59%	Rel Volume	0.79	Prev Close	4.05
Employees	45	LT Debt/Eq	0.45	Earnings	May 06 BMO	SMA200	9.43%	Avg Volume	398.26K	Price	4.12
IPO	Nov 16, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.00% -22.84%	Trades		Volume	135,949	Change	1.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)